Touchlight Inks Patent License Agreement With Pfizer
February 2, 2024
CNBC
Touchlight, a biotechnology company pioneering enzymatic DNA production, announced a non-exclusive patent license agreement with Pfizer Inc (NYSE: PFE ).
The pharma giant has inked a non-exclusive license agreement with Touchlight to utilize its enzymatic "doggybone DNA" (dbDNA) in the manufacturing ... Full story available on Benzinga.com
SweepCast
Simplest Unusual Options Activity Platform for traders. SweepCast can be used for swing or day traders who are looking to get insights on where Smart money is flowing, sign up today.